Combined intracavitary, systemic antifungal and surgical treatment of Chronic Pulmonary Aspergillosis: experience from an immunocompromised patient

慢性肺曲霉病的腔内、全身抗真菌和外科联合治疗:一位免疫功能低下患者的经验

阅读:3

Abstract

We present a complex case of Chronic Pulmonary Aspergillosis (CPA) caused by Aspergillus fumigatus in a pre-existing lung cavity in an immunocompromised patient with granulomatosis with polyangiitis. Initial treatment with voriconazole was limited due to adverse effects and emerging azole resistance.Aspergillus Subsequent therapy with intravenous and intracavitary amphotericin B was also poorly tolerated and clinically insufficient. The patient underwent left-sided thoracotomy with decortication. As a novel approach, the patient recieved Post-surgical instillation of liposomal amphotericin B directly into the resected cavity, combined with systemic antifungal therapy. Subsequently the patient recovered with long-term remission. This case highlights the potential role of post-operative intracavitary antifungal instillation as an adjunctive strategy in refractory CPA, particularly when conventional medical therapy fails.2012 Elsevier Ltd. All rights reserved.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。